Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants

• click to rate

  Posted by Two Blokes Jun 10 - Filed in Stock - 7 views
  
  MRK wins early FDA approval for RSV antibody Enflonsia in infants, with U.S. launch planned before the 2025-26 season.